Pertussis toxin
Overview[edit]

Pertussis toxin is a protein-based exotoxin produced by the bacterium Bordetella pertussis, which is the causative agent of whooping cough. This toxin is a major virulence factor of the bacterium and plays a crucial role in the pathogenesis of the disease.
Structure[edit]
Pertussis toxin is a multi-subunit protein complex composed of five different subunits, designated S1 through S5. The structure of the toxin is organized into an A-B model, where the A component (S1 subunit) is responsible for the enzymatic activity, and the B component (S2-S5 subunits) facilitates binding to host cells.
Mechanism of Action[edit]
The primary action of pertussis toxin is the ADP-ribosylation of the _ subunit of G-proteins in host cells. This modification inhibits the normal function of G-proteins, leading to the disruption of intracellular signaling pathways. As a result, the toxin interferes with the immune response and contributes to the characteristic symptoms of whooping cough.
Pathogenesis[edit]
Pertussis toxin contributes to the pathogenesis of whooping cough by:
- Inhibiting phagocytosis by immune cells, allowing Bordetella pertussis to evade the host's immune system.
- Disrupting cytokine production, which impairs the immune response.
- Causing lymphocytosis, an increase in lymphocyte count, which is a hallmark of whooping cough.
Clinical Significance[edit]
Pertussis toxin is a key target for vaccination strategies. The acellular pertussis vaccine includes inactivated pertussis toxin as one of its components, which helps to induce immunity against the toxin and protect against whooping cough.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian